Variability Seen in Use of Influenza Antiviral Agents in Children
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 13, 2023 -- Considerable variability is seen in the use of influenza antiviral agents in children, with low use among young children at high risk for complications, according to a study published online Nov. 13 in Pediatrics.
James W. Antoon, M.D., Ph.D., M.P.H., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues conducted a cross-sectional study of outpatient and emergency department prescription claims in individuals younger than 18 years. The rate of antiviral dispensing per 1,000 enrolled children was examined as the primary outcome.
A total of 1,416,764 unique antiviral dispensings between 2010 and 2019 were included in the analysis. The researchers found that the most frequently prescribed antiviral was oseltamivir (99.8 percent). The rate of dispensing varied from 4.4 to 48.6 per 1,000 enrolled children. The highest treatment rates were seen for older children (12 to 17 years), during the 2017 to 2018 influenza season, and in the East South Central region. Among young children (younger than 2 years of age) at a high risk for influenza complications, guideline-concordant antiviral use was low (<40 percent). For prescriptions, the inflation-adjusted cost was $208,458,979, and the median cost varied from $111 to $151.
"Although we must improve influenza vaccination rates, antiviral agents also must play a larger role in the prophylaxis and treatment of influenza infection," Pia S. Pannaraj, M.D., M.P.H., from the University of California in San Diego, writes in an accompanying editorial. "When it comes to influenza, we should be using all the tools in our toolbox."
One author disclosed ties to Merck, and a second disclosed ties to Biomerieux.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season
WEDNESDAY, May 22, 2024 -- In fall/winter 2023/2024, the risk for death in patients hospitalized for COVID-19 was greater than the risk for death in patients hospitalized for...
Global Life Expectancy, Disease Burden Set to Keep Improving
WEDNESDAY, May 22, 2024 -- Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease...
Preparedness for HPAI A(H5N1) Virus Varies Across Jurisdictions
TUESDAY, May 21, 2024 -- Variation is seen in preparedness and response to highly pathogenic avian influenza (HPAI) A(H5N1) viruses, according to a research letter published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.